Advanced BioMedical Technologies, Inc.
ABMT
$0.00
$0.000.00%
OTC PK
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 109.80K | 110.60K | 110.30K | 123.60K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 109.80K | 110.60K | 110.30K | 123.60K | -- |
| Cost of Revenue | 28.10K | 28.90K | 28.80K | 51.80K | -- |
| Gross Profit | 81.70K | 81.70K | 81.50K | 71.80K | -- |
| SG&A Expenses | 235.50K | 244.00K | 264.00K | 275.10K | -- |
| Depreciation & Amortization | 49.80K | 57.80K | 60.10K | 60.40K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 533.60K | 539.00K | 545.90K | 570.10K | -- |
| Operating Income | -423.80K | -428.40K | -435.50K | -446.50K | -- |
| Income Before Tax | -753.10K | -759.60K | -780.20K | -672.00K | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.75 | -0.76 | -0.78 | -0.67 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -753.10K | -759.60K | -780.20K | -672.00K | -- |
| EBIT | -423.80K | -428.40K | -435.50K | -446.50K | -- |
| EBITDA | -408.90K | -412.80K | -419.60K | -429.60K | -- |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -- |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -- |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -- |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -- |
| Average Basic Shares Outstanding | 280.66M | 280.41M | 280.13M | 279.78M | -- |
| Average Diluted Shares Outstanding | 281.22M | 280.97M | 280.60M | 280.18M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |